Company research
BioCardia, Inc.
CIK 925741Updated Nov 14, 2026
SecurityBCDA · NASDAQ · equity
Historical securities (1)
BCDAW · NASDAQ · warrant · closed Aug 2, 2024Name history
Tiger X Medical, Inc. · through Oct 17, 2016Cardo Medical, Inc. · through May 25, 2011CLICKNSETTLE COM INC · through Oct 20, 2008NAM CORP · through Mar 29, 2000
BCDA price & chart
Loading TradingView…
NASDAQ:BCDA on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Results of Operations and Financial Condition
Items 2.02, 9.01
10-Q filing
Other Events
Items 8.01, 9.01
Other Events
Items 8.01, 9.01
Other Events
Items 8.01, 9.01
Show 5 more recent filings
Other Events
Items 8.01, 9.01
Other Events
Items 8.01, 9.01
Other Events
Items 8.01
Other Events
Items 8.01, 9.01
Regulation FD Disclosure
Items 7.01, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 6,148,000Source | 6,267,000Source | 4,755,000Source | 2,089,000Source | 2,890,000Source | 1,712,000Source | 2,166,000Source | 2,679,000Source | 3,413,000Source | 3,724,000Source | 2,987,000Source | 9,793,000Source |
| Property, Plant and Equipment, NetUSD | 13,000Source | 47,000Source | 13,000Source | 17,000Source | 61,000Source | 16,000Source | 16,000Source | 75,000Source | 16,000Source | 33,000Source | 94,000Source | 170,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 5,287,000Source | 4,930,000Source | 4,117,000Source | 980,000Source | 1,421,000Source | 951,000Source | 949,000Source | 949,000Source | 2,496,000Source | 2,371,000Source | 1,103,000Source | 7,363,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | 10,000Source | 30,000Source | 10,000Source | 10,000Source | 20,000Source | — | 58,000Source | 20,000Source | 0Source | 63,000Source | 201,000Source |
| Assets, CurrentUSD | 5,365,000Source | 5,056,000Source | 4,298,000Source | 1,199,000Source | 1,573,000Source | 1,140,000Source | 1,173,000Source | 1,259,000Source | 2,732,000Source | 2,622,000Source | 1,461,000Source | 7,864,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 78,000Source | 116,000Source | 151,000Source | 209,000Source | 142,000Source | 169,000Source | 224,000Source | 252,000Source | 216,000Source | 251,000Source | 295,000Source | 300,000Source |
| Operating Lease, Right-of-Use AssetUSD | 599,000Source | 993,000Source | 273,000Source | 702,000Source | 1,085,000Source | 385,000Source | 801,000Source | 1,174,000Source | 494,000Source | 898,000Source | 1,261,000Source | 1,588,000Source |
| Other Assets, NoncurrentUSD | 171,000Source | 171,000Source | 171,000Source | 171,000Source | 171,000Source | 171,000Source | 171,000Source | 171,000Source | 171,000Source | 171,000Source | 171,000Source | 171,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 3,521,000Source | 3,514,000Source | 2,055,000Source | 3,975,000Source | 4,851,000Source | 2,778,000Source | 3,686,000Source | 4,954,000Source | 2,518,000Source | 2,887,000Source | 4,590,000Source | 4,901,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 11,000Source | 5,000Source | 15,000Source | 6,000Source | 2,000Source | 11,000Source | 5,000Source | 27,000Source | 11,000Source | 5,000Source | 24,000Source | 20,000Source |
| Additional Paid in CapitalUSD | 168,981,000Source | 160,573,000Source | 174,906,000Source | 162,990,000Source | 154,125,000Source | 169,531,000Source | 161,308,000Source | 152,140,000Source | 169,233,000Source | 160,953,000Source | 150,548,000Source | 145,476,000Source |
| Retained Earnings (Accumulated Deficit)USD | -166,365,000Source | -157,825,000Source | -172,221,000Source | -164,882,000Source | -156,088,000Source | -170,608,000Source | -162,833,000Source | -154,442,000Source | -168,349,000Source | -160,121,000Source | -152,175,000Source | -140,604,000Source |
| Stockholders' Equity Attributable to ParentUSD | 2,627,000Source | 2,753,000Source | 2,700,000Source | -1,886,000Source | -1,961,000Source | -1,066,000Source | -1,520,000Source | -2,275,000Source | 895,000Source | 837,000Source | -1,603,000Source | 4,892,000Source |
| Liabilities and EquityUSD | 6,148,000Source | 6,267,000Source | 4,755,000Source | 2,089,000Source | 2,890,000Source | 1,712,000Source | 2,166,000Source | 2,679,000Source | 3,413,000Source | 3,724,000Source | 2,987,000Source | 9,793,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 3,310,000Source | 2,840,000Source | 2,055,000Source | 3,642,000Source | 4,071,000Source | 2,778,000Source | 3,234,000Source | 4,071,000Source | 2,432,000Source | 2,321,000Source | 3,608,000Source | 3,585,000Source |
| Operating Lease, Liability, CurrentUSD | 427,000Source | 371,000Source | 293,000Source | 412,000Source | 358,000Source | 412,000Source | 398,000Source | 345,000Source | 442,000Source | 385,000Source | 333,000Source | 315,000Source |
| Accounts Payable, CurrentUSD | 1,080,000Source | 569,000Source | 541,000Source | 1,233,000Source | 1,447,000Source | 820,000Source | 818,000Source | 1,030,000Source | 641,000Source | 385,000Source | 890,000Source | 683,000Source |
| Operating Lease, Liability, NoncurrentUSD | 211,000Source | 674,000Source | 0Source | 333,000Source | 780,000Source | 0Source | 452,000Source | 883,000Source | 86,000Source | 566,000Source | 982,000Source | 1,316,000Source |
| Additional Financial Items | ||||||||||||
| Accounts Receivable, after Allowance for Credit LossUSD | — | — | — | — | — | — | — | — | — | 0Source | — | — |
| Accrued Liabilities, CurrentUSD | 108,000Source | 28,000Source | 30,000Source | 41,000Source | 4,000Source | 52,000Source | 243,000Source | 116,000Source | 34,000Source | 22,000Source | 75,000Source | 157,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | 0Source | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 3,000Source | 12,000Source | 24,000Source | 67,000Source | 84,000Source | 82,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 113,000Source | 170,000Source | 430,000Source | 741,000Source | 1,030,000Source | 1,183,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | — | 0Source | 20,000Source | -97,000Source | -138,000Source | 54,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 247,000Source | 422,000Source | 163,000Source | -316,000Source | 184,000Source | 4,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -1,659,000Source | -1,618,000Source | -7,436,000Source | -8,026,000Source | -9,974,000Source | -10,561,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -3,000Source | 0Source | -7,000Source | -6,000Source | -12,000Source | -70,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 3,000Source | 0Source | 7,000Source | 6,000Source | 12,000Source | 70,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | — | — | 197,000Source | — | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 117,000Source | 196,000Source | 7,568,000Source | 9,300,000Source | 3,726,000Source | 5,122,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -1,545,000Source | -1,422,000Source | 125,000Source | 1,268,000Source | -6,260,000Source | -5,509,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 77,000Source | 177,000Source | 109,000Source | 98,000Source | 113,000Source | 170,000Source | 430,000Source | 741,000Source | 1,030,000Source | 1,183,000Source |
| DepreciationUSD | — | — | 4,000Source | 16,000Source | — | 5,000Source | — | 12,000Source | 24,000Source | 67,000Source | 84,000Source | 82,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | — | — | — | 0Source | -4,000Source | 0Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,483,000Source | -1,737,000Source | -1,613,000Source | -2,049,000Source | -2,259,000Source | -2,712,000Source | -8,228,000Source | -7,946,000Source | -11,571,000Source | -11,907,000Source |
| Nonoperating Income (Expense)USD | — | — | 5,000Source | 19,000Source | 10,000Source | 2,000Source | 7,000Source | 14,000Source | 50,000Source | 55,000Source | 73,000Source | -6,000Source |
| Operating Lease, ExpenseUSD | — | — | 121,000Source | 121,000Source | 120,000Source | 120,000Source | 121,000Source | 121,000Source | — | — | — | 482,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 225,000Source | 212,000Source | 8,690,000Source | 10,552,000Source | 4,388,000Source | 5,540,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 0Source | 0Source | — | 0Source | — | 0Source | 0Source | 58,000Source | 477,000Source | 1,352,000Source |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General and Administrative ExpenseUSD | — | — | 552,000Source | 825,000Source | 730,000Source | 683,000Source | 1,031,000Source | 1,196,000Source | 3,316,000Source | 3,672,000Source | 4,395,000Source | 4,419,000Source |
| Operating Income (Loss)USD | — | — | -1,488,000Source | -1,756,000Source | -1,623,000Source | -2,051,000Source | -2,266,000Source | -2,726,000Source | -8,278,000Source | -8,001,000Source | -11,644,000Source | -11,901,000Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,483,000Source | -1,737,000Source | -1,613,000Source | -2,049,000Source | -2,259,000Source | -2,712,000Source | -8,228,000Source | -7,946,000Source | -11,571,000Source | -11,907,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.24Source | -0.61Source | -0.13Source | -0.4Source | -0.21Source | -0.59Source | -1.23Source | -2.9Source | -0.55Source | -0.67Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 6,277,848Source | 2,827,492Source | 12,093,268Source | 5,059,736Source | 10,812,419Source | 4,635,764Source | 6,666,943Source | 2,743,828Source | 21,179,974Source | 17,720,972Source |
| Additional Financial Items | ||||||||||||
| Costs and ExpensesUSD | — | — | 1,488,000Source | 1,756,000Source | 1,623,000Source | 2,051,000Source | 2,266,000Source | 2,726,000Source | 8,278,000Source | 8,059,000Source | 12,121,000Source | 13,253,000Source |
| Nonoperating Income (Expense)USD | — | — | 5,000Source | 19,000Source | 10,000Source | 2,000Source | 7,000Source | 14,000Source | 50,000Source | 55,000Source | 73,000Source | -6,000Source |
| Operating Lease, ExpenseUSD | — | — | 121,000Source | 121,000Source | 120,000Source | 120,000Source | 121,000Source | 121,000Source | — | — | — | 482,000Source |
| Research and Development ExpenseUSD | — | — | 936,000Source | 931,000Source | 893,000Source | 1,368,000Source | 1,235,000Source | 1,530,000Source | 4,962,000Source | 4,387,000Source | 7,726,000Source | 8,834,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 0Source | 0Source | — | 0Source | — | 0Source | 0Source | 58,000Source | 477,000Source | 1,352,000Source |
| Earnings Per Share, Diluted | — | — | — | — | — | —Source | —Source | —Source | — | — | — | — |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | — | —Source | —Source | —Source | — | — | — | — |
Offerings
Registration 333-290283
- Gross proceeds
- 6000000.0
- Net proceeds
- 5636980.0
- Deal price
- 1.25
- Shares
- 4800000
- Offering amount
- $0.9
- Offering price
- $1.25
- Ticker
- BCDA